Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis
暂无分享,去创建一个
[1] N Iida,et al. The Cell Adhesion Molecule, GP116, Is a New CD44 Variant (ex14/v10) Involved in Hyaluronic Acid Binding and Endothelial Cell Proliferation* , 1996, The Journal of Biological Chemistry.
[2] L. Bourguignon,et al. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion. , 1996, Oncogene.
[3] K. Friedrichs,et al. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. , 1995, Cancer research.
[4] B. Dutrillaux,et al. CD44 expression patterns in breast and colon tumors: A pcr‐based study of splice variants , 1995, International journal of cancer.
[5] H. Liao,et al. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. , 1995, Journal of immunology.
[6] E. Ostermann,et al. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type. , 1995, Biochemical and biophysical research communications.
[7] W. Eisterer,et al. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. , 1995, Blood.
[8] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.
[9] R. Strieter,et al. Role of C‐X‐C chemokines as regulators of angiogenesis in lung cancer , 1995, Journal of leukocyte biology.
[10] A. Droll,et al. Adhesive interactions between alternatively spliced CD44 isoforms , 1995, Journal of Biological Chemistry.
[11] H. Sorimachi,et al. A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan , 1995, The Journal of Biological Chemistry.
[12] P. Herrlich,et al. CD44 variant exon epitopes in primary breast cancer and length of survival , 1995, The Lancet.
[13] S. Kumar,et al. The role of hyaluronan in tumour neovascularization (review) , 1995, International journal of cancer.
[14] P. Herrlich,et al. Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancer , 1995, International journal of cancer.
[15] J. Bell,et al. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon , 1995, The Journal of cell biology.
[16] L. Bourguignon,et al. New CD44 splice variants associated with human breast cancers , 1995, Journal of cellular physiology.
[17] J. Oosting,et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins , 1994, The Lancet.
[18] L. Bourguignon,et al. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function , 1994, The Journal of cell biology.
[19] M. Culty,et al. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential , 1994, Journal of cellular physiology.
[20] M. Chaitin,et al. Immunocytochemical localization of CD44 in the mouse retina. , 1994, Experimental eye research.
[21] R. Savani,et al. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. , 1994, The EMBO journal.
[22] X. Chen,et al. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. , 1993, Journal of immunology.
[23] J. Bergh,et al. Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. , 1993, Human pathology.
[24] Trifaró Jm,et al. Cytoskeleton dynamics during neurotransmitter release , 1993 .
[25] S Toikkanen,et al. Glycoprotein CD44 expression and its association with survival in breast cancer. , 1993, The American journal of pathology.
[26] P. Herrlich,et al. CD44 splice variants: metastases meet lymphocytes. , 1993, Immunology today.
[27] Mark S. Anderson,et al. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44 , 1993, Cell.
[28] S. Jalkanen,et al. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin , 1993, The Journal of cell biology.
[29] I. Stamenkovic,et al. Identification of hyaluronic acid binding sites in the extracellular domain of CD44 , 1993, The Journal of cell biology.
[30] W. T. Chen,et al. Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia. , 1993, Cancer research.
[31] L. Ellis,et al. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases , 1993, The Lancet.
[32] J. Bell,et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Strieter,et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.
[34] K. Ishihara,et al. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition , 1992, The Journal of cell biology.
[35] L. Bourguignon,et al. The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. , 1992, The Journal of biological chemistry.
[36] D. Tarin,et al. Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.
[37] L. Milstone,et al. Identification and characterization of a cell surface proteoglycan on keratinocytes. , 1992, The Journal of investigative dermatology.
[38] L. Bourguignon,et al. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin , 1992, Molecular and cellular biology.
[39] B. Delpech,et al. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: Comparison between invasive and non‐invasive areas , 1992, International journal of cancer.
[40] J. Lillehaug,et al. Reorganization of the cytoskeleton and morphological changes induced by 1,25-dihydroxyvitamin D3 in C3H/10T1/2 mouse embryo fibroblasts: relation to inhibition of proliferation. , 1992, Experimental cell research.
[41] S. Jalkanen,et al. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin , 1992, The Journal of cell biology.
[42] L. Bourguignon,et al. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. , 1991, The Journal of biological chemistry.
[43] R. Humphries,et al. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells , 1991, The Journal of experimental medicine.
[44] L. Bourguignon,et al. Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. , 1991, The Journal of biological chemistry.
[45] Martin Hofmann,et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.
[46] W. Carter,et al. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons , 1991, The Journal of cell biology.
[47] E. Turley,et al. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells , 1991, The Journal of cell biology.
[48] M. Amiot,et al. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.
[49] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[50] E. Butcher,et al. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol 1991 Feb;112(3):following 513] , 1990, The Journal of cell biology.
[51] K. Miyake,et al. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition , 1990, The Journal of experimental medicine.
[52] I. Stamenkovic,et al. CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.
[53] M. Telen,et al. CD44--a molecule involved in leukocyte adherence and T-cell activation. , 1989, Immunology today.
[54] L. Picker,et al. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types , 1989, The Journal of cell biology.
[55] S. Kumar,et al. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. , 1989, Experimental cell research.
[56] L. Bourguignon,et al. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. , 1989, The Journal of biological chemistry.
[57] G. Tarone,et al. Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor. , 1988, Experimental cell research.
[58] William,et al. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. , 1988, The Journal of biological chemistry.
[59] L. Bourguignon,et al. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin , 1988, The Journal of cell biology.
[60] W. Carter. Transformation-dependent alterations is glycoproteins of extracellular matrix of human fibroblasts. Characterization of GP250 and the collagen-like GP140. , 1982, The Journal of biological chemistry.
[61] L. Bourguignon. Chapter 14 Interactions between the Membrane-Cytoskeleton and CD44 during Lymphocyte Signal Transduction and Cell Adhesion , 1996 .
[62] U. Günthert,et al. Current Topics in Microbiology and Immunology (1993) Volume on Adhesion in Leukocyte Homing and Differentiation (eds D. Dunon, C. R. Mackay, and B. A. Imhof) CD44: a multitude of isoforms with diverse functions , 2007 .
[63] P. Kincade,et al. CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.
[64] K. Miyake,et al. A new cell adhesion mechanism involving hyaluronate and CD44. , 1990, Current topics in microbiology and immunology.
[65] M. Morrison. Lactoperoxidase-catalyzed iodination as a tool for investigation of proteins. , 1980, Methods in enzymology.